Safety and Efficacy of Liposomal Cytarabine/Daunorubicin (CPX-351) in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia

被引：1
|
作者：
Przespolewski, Amanda [1 ]
Talati, Chetasi [2 ]
Vachhani, Pankit [3 ]
Sanikommu, Srinivasa Reddy [4 ]
Thota, Swapna [1 ]
Baron, Jeffrey [1 ]
Griffiths, Elizabeth A. [1 ]
Thompson, James E. [1 ]
Sweet, Kendra L. [5 ]
Wang, Eunice S. [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Div Malignant Hematol, Tampa, FL USA
[3] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[4] Carolinas Healthcare Syst, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2677
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
    Przespolewski, Amanda
    Goldberg, Aaron D.
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa R.
    Thota, Swapna
    Waksal, Julian
    Ball, Brian
    Famulare, Christopher
    Stahl, Maximilian
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra
    Wang, Eunice S.
    BLOOD, 2023, 141 (12) : 1489 - 1493
  • [2] Safety and efficacy of CPX-351 in younger patients &lt; 60 years old with secondary acute myeloid leukemia:An updated analysis
    Przespolewski, Amanda Cecile
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa
    Thota, Swapna
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra Lynn
    Wang, Eunice S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Safety and Efficacy of CPX-351 in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia: An Updated Analysis
    Przespolewski, Amanda
    Goldberg, Aaron D.
    Talati, Chetasi
    Fazal, Salman
    Vachhani, Pankit
    Sanikommu, Srinivasa Reddy R.
    Thota, Swapna
    Waksal, Julian
    Ball, Brian
    Famulare, Christopher
    Stahl, Maximilian
    Mckinnell, Zoe
    Baron, Jeffrey
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sweet, Kendra
    Wang, Eunice S.
    BLOOD, 2021, 138
  • [4] Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia
    Ronson, Aaron
    Tvito, Ariella
    Rowe, Jacob M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 369 - 374
  • [5] Liposomal encapsulated cytarabine and daunorubicin (CPX-351) for older patients with acute myeloid leukemia
    Asghari, Hannah
    Lancet, Jeffrey
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1305 - 1312
  • [6] Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
    Chen, Evan C.
    Fathi, Amir T.
    Brunner, Andrew M.
    ONCOTARGETS AND THERAPY, 2018, 11 : 3425 - 3434
  • [7] A phase II study of CPX-351 in younger patients &lt; 60 years old with secondary acute myeloid leukemia: Trial in progress.
    Swaminathan, Mahesh
    Fazal, Salman
    Griffiths, Elizabeth A.
    Thompson, James E.
    Sung, Pamela Jeannette
    Green, Steven Daniel
    Li, Emily
    Said, Meriem
    Belko, Krista
    Mattice, Emmalyn
    Attwood, Kristopher
    Wang, Eunice S.
    Przespolewski, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Cost-Effectiveness of Liposomal Cytarabine-Daunorubicin (CPX-351) Compared to Conventional Cytarabine-Daunorubicin Chemotherapy in Acute Myeloid Leukemia
    Bewersdorf, Jan Philipp
    Goshua, George
    Patel, Kishan K.
    Shallis, Rory M.
    Podoltsev, Nikolai
    Huntington, Scott F.
    Zeidan, Amer M.
    BLOOD, 2021, 138
  • [9] Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia
    Benitez, Lydia L.
    Perissinotti, Anthony J.
    Rausch, Caitlin R.
    Klaus, Jeff
    Clark, Stephen Michael
    Filtz, Michael
    Ratermann, Kelley
    Treptow, Carissa
    Griffin, Shawn
    Olson, Marissa
    Crain, Mallory
    Kadia, Tapan
    Pettit, Kristen
    Burke, Patrick W.
    Bixby, Dale L.
    Marini, Bernard L.
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2184 - 2192
  • [10] CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    Uy, Geoffrey L.
    Cortes, Jorge E.
    Newell, Laura F.
    Lin, Tara L.
    Ritchie, Ellen K.
    Stuart, Robert K.
    Strickland, Stephen A.
    Hogge, Donna
    Solomon, Scott R.
    Stone, Richard M.
    Bixby, Dale L.
    Kolitz, Jonathan E.
    Schiller, Gary J.
    Wieduwilt, Matthew J.
    Ryan, Daniel H.
    Hoering, Antje
    Banerjee, Kamalika
    Chiarella, Michael
    Louie, Arthur C.
    Medeiros, Bruno C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (26) : 2684 - +
12345